In 2021, research led by Ryan Flynn, MD, PhD, and his mentor, Nobel laureate Carolyn Bertozzi, PhD, opened a new chapter in biology, characterizing a new kind of player on the cell surface: glycoRNAs.

Liso-Cel is a type of CAR T-cell therapy — a revolutionary approach that uses a patient's own immune cells to fight cancer.

A newly identified subtype of Castleman disease will help diagnose and properly treat thousands of patients who have been ...

as accompanied by frequent vacuole formation starting at 32 dpt and the resultant “Sertoli cell-only syndrome”. These data indicate that Nat10 is essential for the maintenance of steady-state ...

In the first comprehensive, cell-by-cell ... in Tourette syndrome, suggesting new therapeutic directions. What makes this study particularly groundbreaking is that it not only confirms previous ...

Minor fluid retention and an occasional sterile abscess at the site of injection of the aqueous suspension were the only complications. Many of the patients reported a sense of well-being ...

From the Department of Cardiology and Angiology I, University Heart Center Freiburg, Germany (D.W.) Faculty of Medicine, University of Freiburg, Germany (D.W.) K. Ley has received research funding for ...

The successful demonstration suggests that a similar strategy could be used to treat short bowel syndrome ... SATB2's key role in maintaining colon cells' "identity" in research published in ...

Mast cell activation syndrome, or disease (MCAS), is a condition that causes mast cells to release these substances too frequently, resulting in severe allergic reactions. After detecting an ...